Pinjiang Cao

618 total citations
16 papers, 518 citations indexed

About

Pinjiang Cao is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Pinjiang Cao has authored 16 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Pinjiang Cao's work include Cancer Mechanisms and Therapy (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Pinjiang Cao is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Pinjiang Cao collaborates with scholars based in Canada, United States and China. Pinjiang Cao's co-authors include David W. Hedley, Ines Lohse, Aaron D. Schimmer, Nhu‐An Pham, Melania Pintilie, James W. Jacobberger, Trevor Do, Shyh‐Dar Li, Bryan Hoang and Mark J. Ernsting and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical Journal.

In The Last Decade

Pinjiang Cao

15 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pinjiang Cao Canada 11 327 176 91 87 74 16 518
Attila Bíró Hungary 11 320 1.0× 236 1.3× 180 2.0× 75 0.9× 54 0.7× 20 762
Fang Sui China 14 394 1.2× 137 0.8× 68 0.7× 142 1.6× 85 1.1× 33 663
Gerald Manorek United States 13 325 1.0× 321 1.8× 49 0.5× 136 1.6× 36 0.5× 18 739
Bikash Chandra Jena India 13 451 1.4× 144 0.8× 75 0.8× 236 2.7× 79 1.1× 24 667
Pindong Li China 15 340 1.0× 130 0.7× 89 1.0× 169 1.9× 56 0.8× 29 614
Shichao Yan China 9 321 1.0× 233 1.3× 46 0.5× 187 2.1× 101 1.4× 14 624
Marina Stantic Australia 12 449 1.4× 266 1.5× 68 0.7× 225 2.6× 56 0.8× 14 699
Sylaja Murikipudi United States 6 225 0.7× 238 1.4× 41 0.5× 95 1.1× 56 0.8× 8 470
Guanggai Xia China 12 216 0.7× 182 1.0× 91 1.0× 153 1.8× 56 0.8× 17 534
Bingxue Shang China 11 318 1.0× 123 0.7× 82 0.9× 126 1.4× 34 0.5× 17 594

Countries citing papers authored by Pinjiang Cao

Since Specialization
Citations

This map shows the geographic impact of Pinjiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinjiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinjiang Cao more than expected).

Fields of papers citing papers by Pinjiang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinjiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinjiang Cao. The network helps show where Pinjiang Cao may publish in the future.

Co-authorship network of co-authors of Pinjiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Pinjiang Cao. A scholar is included among the top collaborators of Pinjiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinjiang Cao. Pinjiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cao, Pinjiang, Nhu‐An Pham, Matthew Waas, et al.. (2025). Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms. British Journal of Cancer. 134(1). 165–174.
2.
Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations
3.
Lohse, Ines, Jacqueline M. Mason, Pinjiang Cao, et al.. (2016). Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. Oncotarget. 8(2). 3064–3071. 44 indexed citations
4.
Lohse, Ines, Ramya Kumareswaran, Pinjiang Cao, et al.. (2016). Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts. PLoS ONE. 11(12). e0167272–e0167272. 22 indexed citations
5.
Lohse, Ines, Pinjiang Cao, Melania Pintilie, et al.. (2016). Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302. Oncotarget. 7(23). 33571–33580. 39 indexed citations
6.
Ernsting, Mark J., Bryan Hoang, Ines Lohse, et al.. (2015). Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. Journal of Controlled Release. 206. 122–130. 114 indexed citations
7.
Lohse, Ines, Pinjiang Cao, Trevor Do, et al.. (2013). Abstract B282: The PLK-4 inhibitor CFI-400945 reduces tumor growth in patient-derived pancreatic xenografts.. Molecular Cancer Therapeutics. 12(11_Supplement). B282–B282. 1 indexed citations
8.
Xu, Junyao, Jennifer J. Knox, Emin Ibrahimov, et al.. (2013). Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for treatment of biliary cancer.. Journal of Clinical Oncology. 31(4_suppl). 196–196. 1 indexed citations
9.
Xu, Junyao, Jennifer J. Knox, Emin Ibrahimov, et al.. (2012). Sequence Dependence of MEK Inhibitor AZD6244 Combined with Gemcitabine for the Treatment of Biliary Cancer. Clinical Cancer Research. 19(1). 118–127. 24 indexed citations
10.
Simpson, Craig D., Pinjiang Cao, Sue Chow, et al.. (2012). Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis. PLoS ONE. 7(7). e41102–e41102. 26 indexed citations
11.
Pham, Nhu‐An, Ming‐Sound Tsao, Pinjiang Cao, & David W. Hedley. (2007). Dissociation of Gemcitabine Sensitivity and Protein Kinase B Signaling in Pancreatic Ductal Adenocarcinoma Models. Pancreas. 35(3). e16–e26. 13 indexed citations
12.
13.
Zhang, Wenli, Jiri Vajsar, Pinjiang Cao, et al.. (2003). Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents. Clinical Biochemistry. 36(5). 339–344. 38 indexed citations
14.
Zhang, Wenli, Jiri Vajsar, Pinjiang Cao, et al.. (2003). Zhang, W. et al. Enzymatic diagnostic test for muscle-eye-brain type congenital muscular dystrophy using commercially available reagents. Clin. Biochem. 36, 339-344. 9 indexed citations
15.
16.
Cao, Pinjiang, et al.. (2002). [Combined treatment for locally advanced carcinoma of uterine cervix].. PubMed. 24(5). 508–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Attila Bíró Breakdown of academic impact, for papers by Fang Sui Breakdown of academic impact, for papers by Gerald Manorek Breakdown of academic impact, for papers by Bikash Chandra Jena Breakdown of academic impact, for papers by Pindong Li Breakdown of academic impact, for papers by Shichao Yan Breakdown of academic impact, for papers by Marina Stantic Breakdown of academic impact, for papers by Sylaja Murikipudi Breakdown of academic impact, for papers by Guanggai Xia Breakdown of academic impact, for papers by Bingxue Shang
Rankless by CCL
2026